128 related articles for article (PubMed ID: 34334378)
21. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.
Gabriel AS; Lafta FM; Schwalbe EC; Nakjang S; Cockell SJ; Iliasova A; Enshaei A; Schwab C; Rand V; Clifford SC; Kinsey SE; Mitchell CD; Vora A; Harrison CJ; Moorman AV; Strathdee G
Epigenetics; 2015; 10(8):717-26. PubMed ID: 26237075
[TBL] [Abstract][Full Text] [Related]
23. Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia.
Almamun M; Levinson BT; van Swaay AC; Johnson NT; McKay SD; Arthur GL; Davis JW; Taylor KH
Epigenetics; 2015; 10(9):882-90. PubMed ID: 26308964
[TBL] [Abstract][Full Text] [Related]
24. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.
Dunwell T; Hesson L; Rauch TA; Wang L; Clark RE; Dallol A; Gentle D; Catchpoole D; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Feb; 9():44. PubMed ID: 20184741
[TBL] [Abstract][Full Text] [Related]
25. History of Parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia.
Vasconcelos GM; Christensen BC; Houseman EA; Xiao J; Marsit CJ; Wiencke JK; Zheng S; Karagas MR; Nelson HH; Wrensch MR; Kelsey KT; Pombo-de-Oliveira MS; Wiemels JL
Epigenetics; 2011 Dec; 6(12):1436-43. PubMed ID: 22139573
[TBL] [Abstract][Full Text] [Related]
26. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.
Stumpel DJ; Schneider P; van Roon EH; Boer JM; de Lorenzo P; Valsecchi MG; de Menezes RX; Pieters R; Stam RW
Blood; 2009 Dec; 114(27):5490-8. PubMed ID: 19855078
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
28. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.
Schäfer V; Ernst J; Rinke J; Winkelmann N; Beck JF; Hochhaus A; Gruhn B; Ernst T
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1641-50. PubMed ID: 27169594
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic remodeling in B-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures.
Lee ST; Muench MO; Fomin ME; Xiao J; Zhou M; de Smith A; Martín-Subero JI; Heath S; Houseman EA; Roy R; Wrensch M; Wiencke J; Metayer C; Wiemels JL
Nucleic Acids Res; 2015 Mar; 43(5):2590-602. PubMed ID: 25690899
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia.
Nordlund J; Bäcklin CL; Wahlberg P; Busche S; Berglund EC; Eloranta ML; Flaegstad T; Forestier E; Frost BM; Harila-Saari A; Heyman M; Jónsson OG; Larsson R; Palle J; Rönnblom L; Schmiegelow K; Sinnett D; Söderhäll S; Pastinen T; Gustafsson MG; Lönnerholm G; Syvänen AC
Genome Biol; 2013 Sep; 14(9):r105. PubMed ID: 24063430
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of two CpG sites upstream of CASP8AP2 promoter influences gene expression and treatment outcome in childhood acute lymphoblastic leukemia.
Li ZG; Jiao Y; Li WJ; Deng GR; Cui L; Gao C; Zhao XX; Wu MY; Jia HT
Leuk Res; 2013 Oct; 37(10):1287-93. PubMed ID: 23953914
[TBL] [Abstract][Full Text] [Related]
32. Differential WNT gene expression in various subtypes of acute lymphoblastic leukemia.
Memarian A; Vosough P; Asgarian-Omran H; Tabrizi M; Shabani M; Shokri F
Iran J Immunol; 2012 Mar; 9(1):61-71. PubMed ID: 22426169
[TBL] [Abstract][Full Text] [Related]
33. Methylation of the promoter region of the MTRR gene in childhood acute lymphoblastic leukemia.
Bai J; Li L; Li Y; Chen Q; Zhang L; Xie X
Oncol Rep; 2019 Jun; 41(6):3488-3498. PubMed ID: 31002356
[TBL] [Abstract][Full Text] [Related]
34. Epigenetics in pediatric acute lymphoblastic leukemia.
Nordlund J; Syvänen AC
Semin Cancer Biol; 2018 Aug; 51():129-138. PubMed ID: 28887175
[TBL] [Abstract][Full Text] [Related]
35. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
[TBL] [Abstract][Full Text] [Related]
36. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
37. Validation of DNA methylation biomarkers for diagnosis of acute lymphoblastic leukemia.
Chatterton Z; Burke D; Emslie KR; Craig JM; Ng J; Ashley DM; Mechinaud F; Saffery R; Wong NC
Clin Chem; 2014 Jul; 60(7):995-1003. PubMed ID: 24829271
[TBL] [Abstract][Full Text] [Related]
38. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Artieda P; Cordeu L; Lahortiga I; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
Int J Cancer; 2006 Apr; 118(8):1945-53. PubMed ID: 16287063
[TBL] [Abstract][Full Text] [Related]
39. TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia.
Musialik E; Bujko M; Wypych A; Matysiak M; Siedlecki JA
Hematol Rep; 2014 Jan; 6(1):5333. PubMed ID: 24711921
[TBL] [Abstract][Full Text] [Related]
40. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
